Background: Treatment of high-grade glioma consists of fractionated radiation therapy (RT) ± chemotherapy. The incidence/significance of neurological toxicity (NT) in this disease is not known. We evaluated the relationship between acute and chronic NT, and ultimate outcome, as well as risk factors for NT from the RTOG database.
American Society of Clinical Oncology (ASCO) 46th Annual Meeting June 4-8, Chicago, IL.
Lawrence, Y. R.; Wang, M.; Dicker, A. P.; Andrews, D. W.; Curran, W. J.; Michalski, J. M.; Souhami, L.; Yung, W. A.; and Mehta, M.
"Acute Neurological Toxicity (NT) and Long-Term Outcomes in High-grade Glioma RTOG Trials,"
Bodine Journal: Vol. 3:
1, Article 6.
Available at: https://jdc.jefferson.edu/bodinejournal/vol3/iss1/6